Therefore, a recent study suggesting high-level EpoR expression in head and neck tumours correlated with tumour progression and worse survival in patients administered ESAs (Henke et al, 2006) most likely identified the well-know association of HSP70 and worse prognosis (Schmitt et al, 2007). The gene discussed is EPOR; the disease is neoplasm.